SFX by Ex Libris Inc.

Title:	Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kB binding site as a novel molecular strategy
Source:	Gene Therapy [0969-7128] Yoshimura, S yr:2001

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Curtiss, Peter K. "Emerging role of toll-like receptors in atherosclerosis." Journal of lipid research 50.Suppl. S (2008): -5.
description	2.	Barrat, Franck J J. "Development of TLR inhibitors for the treatment of autoimmune diseases." Immunological reviews 223.1 (2008): 271-83.
description	3.	Loppnow, H. "Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms." Innate immunity 14.2 (2008): 63-87.
description	4.	Dunzendorfer, S. "Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity." Circulation research 95.7 (2004): 684-91.
description	5.	Tedgui, A. "Molecular mechanisms of the vascular responses to haemodynamic forces." Journal of internal medicine 259.4: 381-92.
description	6.	Tobias, P S S. "Toll-like receptors in atherosclerosis." Biochemical society transactions 35.Pt 6 (2008): 1453-5.
description	7.	Bode, Konrad A A. "Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment." Immunology 122.4 (2007): 596-606.
description	8.	Wang, R-F F. "Toll-like receptors and immune regulation: implications for cancer therapy." Oncogene 27.2 (2007): 181-9.
description	9.	Fujiwara, K. "Platelet endothelial cell adhesion molecule-1 and mechanotransduction in vascular endothelial cells." Journal of internal medicine 259.4 (2006): 373-380.
description	10.	Gruber, Faith J. "Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice." The FASEB journal 22.10 (2008): 3549-60.
description	11.	Xu, Q. "Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model." Kidney international 70.2 (2006): 315-20.
description	12.	Takeshita, F. "TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF." European journal of immunology 35.8 (2005): 2477-2485.
description	13.	Ley, K. "Immune and inflammatory mechanisms of atherosclerosis (*)." Annual review of immunology 27.1 (2009): 165-97.
description	14.	Pinderski, L. "Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes." Circulation research 90.10 (2002): 1064-1071.
description	15.	Zernecke, A. "Chemokines in atherosclerosis: an update." Arteriosclerosis, thrombosis, and vascular biology 28.11 (2008): 1897-908.
description	16.	Grundy, -. "Atherosclerosis: pathology, pathogenesis, and role of risk factors." Disease-a-month 29.9 (1983): 1-58.
description	17.	Sarzani, R. "Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans." Journal of hypertension 26.5 (2008): 831-843.
description	18.	Dai, G. "Distinct Endothelial Phenotypes Evoked by Arterial Waveforms Derived from Atherosclerosis-Susceptible and-Resistant Regions of Human Vasculature." Proceedings of the National Academy of Sciences of the United States of America 101.41 (2004): 14871-14876.
description	19.	Wu, Christina C N C. "Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand." Proceedings of the National Academy of Sciences of the United States of America 104.10 (2007): 3990-5.
description	20.	Mullick, Adam E E. "Modulation of atherosclerosis in mice by Toll-like receptor 2." The journal of clinical investigation 115.11 (2005): 3149-56.